CELLTRION Logo (WIPO, 01.04.2011)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke CELLTRION wurde als Bildmarke am 01.04.2011 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Kreise #Briefe, die eine besondere Form des Schreibens darstellen #Farben #Mehrere Kreise, nebeneinanderliegend, tangential oder sich überschneidend #Buchstabenreihen in verschiedenen Dimensionen #Drei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1087869 |
| Länder | 
|
| Basismarke |
Nr. ,
04. November 2024
|
| Anmeldedatum | 01. April 2011 |
| Ablaufdatum | 01. April 2031 |
Markeninhaber
5F, 19, Academy-ro 51beon-gil,
Yeonsu-gu
KR
Yeonsu-gu
KR
Markenvertreter
23rd Floor, D-Tower (D2),
17 Jongno 3-gil,
KR
Waren und Dienstleistungen
05
Vaccines; medicines for sensory organs; pharmaceutical
preparations for immunity adjustment; biological
preparations; amino acids for medical purposes; antibiotic
preparations; pharmaceutical preparations for respiratory
organs; chemotherapeutics; reagents for measuring hepatitis
B surface antibody; diagnostic preparations for medical use;
acquired immune deficiency syndrome (AIDS) diagnostic
reagents; pharmaceutical preparations for tumor treatment;
pharmaceutical preparations for urogenital organs;
biopharmaceuticals; biopharmaceutical preparations and
substances; biotherapeutic preparations and substances;
biotechnological preparations and substances for medical
purposes; pharmaceuticals; chemical preparations for
pharmaceutical purposes; pills for pharmaceutical purposes;
chemico-pharmaceutical preparations; pharmaceutical
preparations; medicines for human purposes; chemical
reagents for medical or veterinary purposes; diagnostic
reagents for medical use; anti-cancer preparations;
pharmaceutical preparations for treatment and prevention of
autoimmune diseases; pharmaceutical preparations affecting
peripheral nervous system; pharmaceutical preparations
affecting central nervous system
35
Wholesale services in the field of pharmaceutical products;
retail store services in the field of pharmaceutical
products; business agency services for the sale of
pharmaceutical products; commercial intermediary services in
the field of pharmaceutical products; arranging the sale of
pharmaceutical products; business intermediary services in
the field of pharmaceutical products; wholesale services in
the field of biopharmaceutical products; retail store
services in the field of biopharmaceutical products;
business agency services for the sale of biopharmaceutical
products; commercial intermediary services in the field of
biopharmaceutical products; arranging the sale of
biopharmaceutical products; business intermediary services
in the field of biopharmaceutical products
40
Treatment of biopharmaceutical materials; processing of
biopharmaceutical materials for others; contract
manufacturing service in the field of biopharmaceuticals;
contract manufacturing service in the field of
pharmaceuticals
42
Pharmaceutical products research and development; research
and development in the field of biotechnology; biological
research and development; research and development for
others; material testing; chemistry services; chemical
research and analysis; technology research and development
outsourcing services on biopharmaceuticals manufacturing;
consulting services in the field of biotechnology;
pharmaceutical drug research and development service with
animal cell; genetically modified plant research and
development; bacteriological research and development;
research and development in the biopharmaceutical fields;
medical product testing; technology outsourcing services on
selecting medicines; research and development of vaccines
and medicines
44
Experimental pathology services; rental of medical and
health care equipment; medical product information services;
clinical medicine; hospitals; medical assistance services;
biopharmaceutical consulting services; pharmacy services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 02. Dezember 2022 | 2023/2 Gaz | Korrektur | |
| 23. August 2022 | 2022/36 Gaz | Korrektur | |
| 17. März 2022 | 2022/12 Gaz | ST | Ablehnung |
| 01. April 2021 | 2021/24 Gaz | Verlängerung | |
| 04. Januar 2021 | 2021/2 Gaz | KH | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 26. Oktober 2020 | 2021/7 Gaz | DZ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 12. August 2020 | 2020/33 Gaz | LA | Ablehnung |
| 26. Juni 2020 | 2020/27 Gaz | KH | Ablehnung |
| 22. Oktober 2019 | 2019/44 Gaz | DZ | Ablehnung |
| 23. März 2019 | 2019/14 Gaz | US | RAW: Partial Invalidation |
| 28. Dezember 2018 | 2019/6 Gaz | KR | Korrektur |
| 01. Februar 2018 | 2018/8 Gaz | SY | Ablehnung |
| 30. November 2017 | KR | Korrektur | |
| 19. Dezember 2016 | 2017/8 Gaz | KR | Korrektur |
| 25. Juli 2013 | 2013/31 Gaz | MK | Ablehnung |
| 22. Februar 2013 | 2013/9 Gaz | TR | Ablehnung |
| 29. Januar 2013 | 2013/5 Gaz | TM | Ablehnung |
| 04. Januar 2013 | 2013/4 Gaz | MD | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 18. Dezember 2012 | 2013/33 Gaz | KR | RAW: Partial Ceasing Effect |
| 05. Dezember 2012 | 2012/50 Gaz | IL | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 06. November 2012 | 2012/47 Gaz | GE | Ablehnung |
| 16. Oktober 2012 | 2012/42 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. Oktober 2012 | 2012/43 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 10. September 2012 | 2012/37 Gaz | KZ | Ablehnung |
| 07. September 2012 | 2012/37 Gaz | BA | Ablehnung |
| 06. September 2012 | 2012/36 Gaz | VN | Ablehnung |
| 30. August 2012 | 2012/35 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 29. August 2012 | 2012/36 Gaz | SY | Ablehnung |
| 27. August 2012 | 2012/36 Gaz | CH | Ablehnung |
| 20. August 2012 | 2012/35 Gaz | MG | Ablehnung |
| 14. August 2012 | 2012/33 Gaz | UA | Ablehnung |
| 14. August 2012 | 2012/33 Gaz | CU | Ablehnung |
| 13. August 2012 | 2012/46 Gaz | ME | Ablehnung |
| 08. August 2012 | 2012/34 Gaz | MD | Ablehnung |
| 01. August 2012 | 2012/34 Gaz | RS | Ablehnung |
| 27. Juli 2012 | 2012/31 Gaz | AM | Ablehnung |
| 19. Juli 2012 | 2012/31 Gaz | CN | Ablehnung |
| 11. Juli 2012 | 2012/28 Gaz | EM | Ablehnung |
| 27. Juni 2012 | 2012/29 Gaz | KG | Ablehnung |
| 25. Juni 2012 | 2012/27 Gaz | RU | Ablehnung |
| 18. Mai 2012 | 2012/21 Gaz | NO | Ablehnung |
| 04. April 2012 | 2012/17 Gaz | SM | Ablehnung |
| 21. März 2012 | 2012/12 Gaz | CW | Ablehnung |
| 01. März 2012 | 2012/9 Gaz | JP | Ablehnung |
| 29. Februar 2012 | 2012/11 Gaz | IL | Ablehnung |
| 13. Februar 2012 | 2012/7 Gaz | AU | Ablehnung |
| 01. Februar 2012 | 2012/10 Gaz | IS | Ablehnung |
| 06. Januar 2012 | 2012/5 Gaz | SG | Ablehnung |
| 03. Januar 2012 | 2012/2 Gaz | MN | Ablehnung |
| 20. Dezember 2011 | 2011/52 Gaz | MA | Ablehnung |
| 25. November 2011 | 2013/41 Gaz | MC | Ablehnung |
| 23. September 2011 | 2011/39 Gaz | US | Ablehnung |
| 08. September 2011 | 2012/34 Gaz | HR | Ablehnung |
| 01. April 2011 | 2011/34 Gaz | KR | Eintragung |
ID: 141087869